Cognex
$67.47
▲ +3.42%
+$2.23
NYSE · Technology · Scientific & Technical Instruments
· price updated 9h ago
CGNX · NYSE · Technology · Scientific & Technical Instruments · price updated 9h ago
$67.47
▲ +3.42% · +$2.23 today
AI research · $67.47
Operating record
Capital structure
Valuation
Forward P/E
Price against expected earnings
Needs attention · 50% above Sector avg
44.14x
Price / sales
Value assigned to each sales dollar
Rich · Above 8x annual sales
10.37x
Price / FCF
Price against free cash generation
Rich · Above 35x free cash flow
45.03x
EV / EBITDA
Operating value including debt
Rich · Above 22x EBITDA
46.96x
Quality
ROIC
Return earned on invested capital
Reasonable · An 8% to 15% return on capital
10.4%
ROE
Profit generated from shareholder equity
Middle ground · Lagging most sector peers
9.8%
Debt / equity
Balance-sheet leverage
Favorable · Exceptional vs sector peers
0.05x
Current ratio
Short-term assets against liabilities
Strong · Comfortable short-term liquidity
3.64x
Selected financial data sourced from StockAnalysis and refreshed weekly. Figures may be delayed and are for research context, not investment advice.
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| $10.86B | 77.2 | +13.8% | 69 | |
| $929.52B | 18.6 | +167.0% | 93 | |
| $4.86T | 30.7 | +70.7% | 87 | |
| $2.10T | 29.2 | +30.6% | 83 | |
| $38.60B | 83.5 | +205.7% | 83 |
US stock research
Cognex tracked in the US core universe. CGNX was +3.4% in the latest available session at $67.47. Its reported market value was $10.86B with a trailing P/E of 77.2. Latest reported revenue was $1.05B, changing +13.8% year over year, with $142.54M in net income.
Market snapshot updated Aug 3, 2026, 7:59 PM UTC.